Intellia Therapeutics (NTLA) Is Down 15.1% After Phase 3 lonvo-z Data And $180M Equity Raise - Has The Bull Case Changed?
This story is reported by Yahoo Finance. Read what other outlets are saying below, then open the original report for full details.